How Long Does It Take for Cocaine to Wear Off?

The subjective high from cocaine typically peaks within the first hour and fades toward baseline within about two to four hours, but the drug itself lingers in the body much longer than the euphoria does. Cocaine’s elimination half-life in plasma averages roughly 70 to 90 minutes, meaning it takes several half-lives for the drug to clear, and its primary metabolite can be detected in urine for days. The full answer depends heavily on how the cocaine was taken, whether alcohol was involved, how often a person uses, and individual biology.

How the Route of Use Changes the Timeline

The way cocaine enters the body is probably the single biggest factor in how quickly you feel it and how fast it fades. Smoked cocaine (crack) is absorbed into the bloodstream almost instantly, with an absorption half-time of just over one minute. Snorting is considerably slower, with an absorption half-time of about 12 minutes. Intravenous injection falls between the two in terms of how quickly blood levels peak, though the drug distributes rapidly from the blood into tissues with a distribution half-life of about 11 minutes.¹

What this means in practice is that smoking and injecting produce a faster, more intense rush that also drops off more sharply. Snorting produces a slower climb and a more gradual decline. The elimination half-life across routes averaged about 69 minutes in a study dividing subjects into three groups by administration method, though intravenous injection showed a slightly longer elimination half-life of 78 minutes.¹ A separate study measuring repeated oral doses found a mean plasma elimination half-life of about 1.5 hours.²

The bioavailability of snorted cocaine is about 80%, meaning most of what you inhale reaches the bloodstream. Smoked cocaine loses some potency because heat degrades part of the drug before it can be absorbed. These differences help explain why people who smoke cocaine tend to re-dose more frequently: the high arrives faster and leaves faster, which drives a pattern of compulsive redosing that snorting typically does not produce to the same degree.

Why the High Fades Before the Drug Leaves Your Body

One of the more counterintuitive aspects of cocaine is that the euphoria does not track neatly with how much cocaine is actually in your blood. In a study where subjects received intravenous cocaine and researchers maintained constant plasma levels, the feeling of being high peaked at about one hour and then steadily declined toward baseline by four hours, even though blood levels of cocaine had not changed.³ This phenomenon is called acute tolerance, and it means that the brain adapts to cocaine’s presence remarkably quickly.

Cocaine works by blocking the dopamine transporter, the protein that normally recycles dopamine back into the nerve cell after it has done its job. With the transporter blocked, dopamine builds up in the space between neurons, producing the characteristic rush. Research in primates found that after a moderate dose, the dopamine transporter returned to its normal baseline availability at about three hours after injection.⁴ So while the subjective high fades over two to four hours, the underlying effect on dopamine signaling resolves on a loosely similar timescale, though the brain’s adjustment to the flood of dopamine accounts for the feeling wearing off faster than the drug itself clears.

This gap between feeling and pharmacology matters practically. Someone who no longer feels high still has active cocaine in their bloodstream and brain. Cocaine concentrations in the brain can be several times higher than those measured in plasma, and the brain acts as a reservoir that clears more slowly than blood alone might suggest. Redosing because you “don’t feel it anymore” while the drug is still circulating is a meaningful source of overdose risk.

Mixing Cocaine and Alcohol Changes the Math

If you drink while using cocaine, your body produces a third substance called cocaethylene, and it meaningfully extends the drug’s timeline. Cocaethylene is formed when the liver processes cocaine and ethanol simultaneously. It has psychoactive properties similar to cocaine itself and may be more cardiotoxic.⁵

The key detail is the half-life. Cocaethylene’s elimination half-life was measured at about 156 minutes in one controlled study, which is roughly double cocaine’s own half-life. Peak cocaethylene concentrations appeared about three hours after dosing, and the ratio of cocaethylene to cocaine in the blood kept climbing even hours after the last dose. By six hours after the final cocaine dose, cocaethylene concentration had reached about 40% of the cocaine concentration.⁶ In practical terms, this means that people who combine the two substances may still have a pharmacologically active metabolite circulating well after the cocaine itself has been largely eliminated.

There is some disagreement in the literature about whether cocaethylene meaningfully changes how the high feels. One earlier study found that cocaethylene’s appearance in the blood did not seem to alter cocaine’s subjective or cardiovascular effects at the concentrations observed.⁷ But more recent reviews have pointed to the longer-lasting and potentially more intense psychoactive effect as a real concern, especially for cardiovascular risk.⁵ The safest reading of the evidence is that cocaethylene prolongs the period during which your heart and circulatory system are under stress, even if the subjective experience is debatable.

Why Some People Clear Cocaine Faster Than Others

Cocaine is broken down primarily by enzymes in the blood and liver. The most important of these is butyrylcholinesterase, often abbreviated BChE, which chops cocaine into a nontoxic metabolite called ecgonine methyl ester. A second pathway uses carboxylesterase in the liver to produce benzoylecgonine, cocaine’s main urinary metabolite.⁸

The amount and efficiency of your BChE enzyme determines a lot about how quickly cocaine leaves your system. Adding BChE to blood samples shortens cocaine’s half-life in proportion to the amount added.⁹ There are at least 58 known mutations in the gene that codes for BChE, and some of these reduce the enzyme’s activity substantially.¹⁰ Researchers have hypothesized that cocaine users carrying certain BChE gene variants could experience different intensities and durations of effects because of differences in how quickly they clear the drug from their blood.¹¹

In animal models designed to mimic BChE-deficient humans, the practical impact is dramatic. Mice lacking both BChE and carboxylesterase took roughly 2.5 times as long to recover from cocaine’s toxic effects compared to normal mice.¹⁰ You cannot know your BChE status without genetic testing, which means there is no way to predict from the outside whether you are someone who clears cocaine quickly or someone for whom it hangs around longer and does more damage.

Do Men and Women Metabolize Cocaine Differently?

The research here is genuinely contradictory. One controlled study giving intravenous cocaine to men and women found no differences in peak plasma levels, elimination half-life, or subjective effects, and also found no differences between women in the follicular versus luteal phases of their menstrual cycle.¹² But another study using intranasal cocaine found that men achieved significantly higher peak plasma concentrations, detected cocaine’s effects faster, and experienced more episodes of intense effects. Women in that study also showed differences between menstrual cycle phases, with higher peak levels during the follicular phase than the luteal phase.¹³

The discrepancy likely comes down to the route of administration. Intravenous delivery bypasses the absorption step entirely, which removes a major source of variability. Intranasal delivery depends on nasal blood flow, mucosal surface area, and other factors that could plausibly differ by sex. The honest summary is that sex differences in cocaine’s duration are plausible for snorted cocaine but have not been reliably established, and for intravenous delivery, they appear to be minimal or nonexistent.

Chronic Use Slows Elimination

If you use cocaine regularly, the drug takes longer to leave your system than if you use it occasionally. A study comparing active street users to the pharmacokinetic data from single-dose laboratory studies found that cocaine’s half-life was longer in chronic users, even though the half-life of its main metabolite, benzoylecgonine, remained about the same.¹⁴ The implication is that regular cocaine use changes the body’s handling of the parent drug itself, possibly through accumulation in tissues or saturation of metabolic pathways. This means that the standard “one to two hour half-life” figures from laboratory studies may underestimate the actual duration in someone who has been using for days or weeks.

The Crash

Most people who have used cocaine are familiar with the crash: a period of fatigue, low mood, and sometimes irritability that follows the high. The subjective experience is widely described, though systematic human data on its time course are limited. Animal research provides the clearest timeline. Rats given a high dose of cocaine showed an initial phase of hyperactivity and lowered body temperature, followed by a prolonged rebound period of reduced activity and elevated body temperature that peaked around 10 to 14 hours after dosing.¹⁵

The crash is essentially a withdrawal effect. After flooding the brain with dopamine, the sudden absence of the drug leaves dopamine signaling temporarily depleted. This is not the same thing as the drug “wearing off” in a pharmacokinetic sense; it is the brain readjusting to normal conditions. For people who have binged, the crash can be more severe and may last 24 hours or longer, sometimes accompanied by intense cravings, depression, and excessive sleep. In chronic cocaine users, depression and craving during abstinence have been documented to decline gradually over the first several days.¹⁶

How Long Cocaine Shows Up on Drug Tests

Drug tests do not typically look for cocaine itself. They look for benzoylecgonine, the metabolite your body produces as it breaks cocaine down. Benzoylecgonine has a much longer half-life than cocaine, which is why drug tests can detect use well after the high has worn off and the cocaine itself has been eliminated.

For occasional users, a standard urine immunoassay can detect benzoylecgonine for roughly two to four days after a single use. Chronic users are a different story. In a study of people who used cocaine heavily and then stopped, cocaine itself was detectable by immunoassay in saliva and urine for 5 to 10 days during abstinence. More specific lab testing confirmed unmetabolized cocaine in saliva for the first 24 hours and in urine for four to five days.¹⁶ Benzoylecgonine, the metabolite most drug tests target, may remain detectable in urine even longer than those windows in heavy users, sometimes exceeding two weeks, because it accumulates in tissues and washes out gradually.

Hair testing operates on a completely different principle, incorporating drug metabolites into the growing hair shaft. A standard hair test covers about 90 days of history, though this varies by hair growth rate. Blood and saliva tests have much shorter windows, generally 12 to 48 hours for cocaine itself, making them more useful for detecting very recent use.

What Street Cocaine Actually Contains

One variable that rarely comes up in clinical pharmacology studies but matters a great deal in the real world is purity. Street cocaine is almost always cut with other substances, and some of those adulterants have their own pharmacological effects. The most concerning in recent years is levamisole, an antiparasitic drug that has become one of the most common cutting agents found in cocaine supplies worldwide. In the body, levamisole is converted to aminorex, a compound with amphetamine-like stimulant properties and a longer half-life than cocaine.¹⁷

This is relevant to the question of how long cocaine’s effects last because a person using levamisole-adulterated cocaine may experience prolonged stimulant effects that are not actually coming from cocaine at all, but from its adulterant. Beyond the duration issue, levamisole carries its own serious health risks, including a dangerous drop in white blood cell counts, tissue death, and damage to the kidneys and liver.¹⁸ Because users have no way of knowing what their cocaine is cut with, the experienced duration and side effects of any given batch can vary unpredictably from what pharmacology textbooks describe.

Experimental Approaches to Speeding Up Clearance

The fact that cocaine’s duration depends so heavily on enzyme activity has led researchers to explore whether injecting cocaine-degrading enzymes could work as a treatment for overdose. A bacterial enzyme called cocaine esterase (CocE) has been engineered specifically to chew through cocaine in the bloodstream. In animal experiments, even a tiny dose of this enzyme fully protected mice from a lethal dose of cocaine.¹⁹ The engineered enzyme dramatically shortened cocaine’s half-life in both the brain and the blood in these models.

Researchers have also developed thermally stabilized versions of CocE that last longer in the body, making them more practical as a potential emergency treatment.²⁰ None of these enzyme therapies are available as approved treatments in humans yet, but they represent a fundamentally different approach to cocaine toxicity: rather than managing symptoms and waiting for the body to metabolize the drug on its own, you would inject something that destroys the cocaine directly. The concept mirrors how naloxone works for opioid overdose, though the biology is entirely different. Whether this eventually becomes a clinical reality depends on solving the remaining challenges of enzyme stability, immunogenicity, and scaling production for emergency medicine.

Cocaine in Clinical Medicine

It is worth noting that cocaine is still a legal pharmaceutical in some clinical settings, used as a topical anesthetic and vasoconstrictor in certain nasal and throat procedures. In this context, the drug’s short duration of action is considered a feature. Applied topically to mucous membranes, it numbs tissue quickly and constricts blood vessels to reduce bleeding, two properties that are difficult to replicate with a single alternative drug.²¹ The concentrations used medically are controlled and far lower than recreational doses, and the route of administration (topical to a membrane) produces a much more localized and predictable pharmacokinetic profile. Systemic absorption still occurs, which is why patients receiving topical cocaine in a hospital setting are monitored for cardiovascular effects, but the risk profile is worlds apart from recreational use.